Antibody

Korean biotech startup Galux Inc. is making waves on the global stage with its groundbreaking AI-driven platform, GaluxDesign, designed to engineer novel therapeutic antibodies with unprecedented precision. In a recently published study, Galux demonstrated the power of its proprietary technology by successfully designing antibodies for six therapeutic targets—including one without an experimentally known structure. The […]